Navigation Links
Ambrx to Present Data from Antibody Drug Conjugate Program at Upcoming Scientific Conferences

SAN DIEGO, June 22, 2011 /PRNewswire/ -- Ambrx Inc. today announced that Ho Cho, Ph.D., the company's Chief Technology Officer, will present preclinical data from the company's antibody drug conjugate (ADC) programs at five upcoming scientific conferences. The presentations will include data obtained from recent xenograft studies comparing Ambrx ADCs with those created using other technologies.

"Ambrx technology has been clinically validated as safe and efficacious for creating PEGylated proteins, and we have recently focused our efforts on creating site-specific conjugates of antibodies with best-in-class potential," Dr. Cho said. "Preclinical data obtained from partnered and unpartnered programs show us that the application of our technology to creating ADCs has tremendous potential. We look forward to presenting this promising data to the scientific community over the coming months."

At the IBC Life Sciences' Next Generation Protein Therapeutics Summit in San Francisco, Dr. Cho will deliver a presentation titled "Synthetic Biology Applied to Biotherapeutics" at 1:30 p.m. PDT on June 22, 2011.

At the American Chemical Society's 242nd National Meeting in Denver, Dr. Cho will deliver a presentation titled "Protein Medicinal Chemistry with an Expanded Genetic Code" at 9 a.m. MDT on August 29, 2011.

At the Cambridge Healthtech Institute's PEGs Europe conference in Hannover, Germany, Dr. Cho will deliver a presentation titled "Protein Medicinal Chemistry Applied to Antibody Drug Conjugates" at 3:05 p.m. CEST on October 11, 2011.

At the World Antibody Drug Conjugate Summit in San Francisco, Dr. Cho will deliver a presentation titled "Optimized Antibody Drug Conjugates with an Expanded Genetic Code" at 10 a.m. PDT on October 27, 2011.

Dr. Cho will also deliver a presentation at the IBC Life Sciences' Empowered Antibody Therapies Conference, held August 1-3, 2011, in San Francisco.

About Ambrx

Ambrx Inc. is a clinical stage biopharmaceutical company using its broad biologics platform to create best-in-class therapeutics, including antibody drug conjugates and proteins with improved pharmacologic properties. The company is developing ARX201, a long-acting growth hormone that has successfully completed Phase 2b clinical trials. Ambrx is developing several product candidates in collaboration with Eli Lilly and Company, including a Phase 3 compound expected to be launched commercially in 2013. The company has validated its biologics platform through additional partnerships with Pfizer and Merck & Co Inc.  Ambrx is advancing a robust portfolio of product candidates that are optimized for efficacy, safety and ease of use in multiple therapeutic areas.  For additional information, visit

Media Contacts:

David Schull or Ian Stone
Russo Partners
T: (212) 845-4271
T: (619) 528-2220

SOURCE Ambrx Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Proceedings of the National Academy of Sciences Report Superiority of Human Growth Hormone Generated with Ambrx Technology
2. Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
3. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
4. Cempra Pharmaceuticals to Present at the 2011 Wells Fargo Healthcare Conference
5. Winner Medical to Present at Brean Murray, Carret & Co. Beijing China Growth Conference
6. Enox Biopharma, Inc. Will Present at IN3 East Investment in Innovation Conference
7. Metabolic Solutions Development Company to Present Recent Findings on the Therapeutic Potential of Increasing Brown Fat in the Treatment of Diabetes at Annual American Diabetes Association Conference
8. Watson to Present at 2011 Wells Fargo Securities Healthcare Conference
9. Simulated Environment Concepts to Present at National Eagles and Angels Association New York Meeting
10. Radiation Therapy Services Holdings, Inc. to Present at the Wells Fargo Securities 2011 Healthcare Conference
11. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
Post Your Comments:
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new ... affiliate in Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
Breaking Medicine News(10 mins):